Document is current
Any future updates will be listed below
-
Authors
Yang, Xu
Hao, Zhixin
Yao, Ru
Zhang, Jiahui
Lian, Jie
Qu, Yang
Nie, Longzhu
Wang, Zihao
Shi, Jie
Mao, Feng
Shen, Songjie
Pan, Bo
Sun, Qiang
Huo, Li
Zhou, Yidong
-
Funding
Funding for this research was provided by:
Postdoctoral Fellowship Program of CPSF under Grant (GZC20240152)
National Natural Science Foundation of China (82303521)
National Natural Science Foundation of China (82573669)
National High Level Hospital Clinical Research Funding (PUMCH-2025-A-147)
Post-marketing clinical research of innovative drugs by Medical and Health Science and Technology Development Research Center of the National Health Commission (WKZX2024CX103104)
Beijing Natural Science Foundation (L258036)
- License Information
-
More Information
Article History
Received: 22 October 2025
Accepted: 10 April 2026
First Online: 20 April 2026
Declarations
:
: This study was performed in accordance with the Declaration of Helsinki, and it was approved by the Institutional Review Board of Peking Union Medical College Hospital (IRB No. K3629). Written informed consent was collected from all patients before the application of medication.
: Not applicable.
: The authors declare no competing interests.
